Community Research and Development Information Service - CORDIS

Unique breakthrough ex vivo human skin model to predict efficacy and toxicity of subcutaneous drugs

From 2018-06-01 to 2018-11-30, ongoing project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

France

Call for proposal:

H2020-SMEInst-2018-2020-1See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Coordinator

GENOSKIN SAS
France

EU contribution: EUR 50 000


CENTRE PIERRE POTIER, 1 PLACE PIERRE POTIER
31100 TOULOUSE
France
See on map
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top